2019
DOI: 10.1007/s11255-019-02310-2
|View full text |Cite
|
Sign up to set email alerts
|

The prevalence of frailty in patients on hemodialysis: a systematic review and meta-analysis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
17
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 29 publications
(18 citation statements)
references
References 26 publications
1
17
0
Order By: Relevance
“…Importantly, this review revealed that the prevalence of frailty in ESRD patients on hemodialysis was approximately 43%. Our finding was similar to a recent meta-analysis [42] that showed a 34% prevalence of frailty in patients undergoing hemodialysis. A systematic review by Chowdhury et al also confirmed that the prevalence of frailty in dialysis patients was higher compared to non-dialysis patients [43].…”
Section: Discussionsupporting
confidence: 92%
“…Importantly, this review revealed that the prevalence of frailty in ESRD patients on hemodialysis was approximately 43%. Our finding was similar to a recent meta-analysis [42] that showed a 34% prevalence of frailty in patients undergoing hemodialysis. A systematic review by Chowdhury et al also confirmed that the prevalence of frailty in dialysis patients was higher compared to non-dialysis patients [43].…”
Section: Discussionsupporting
confidence: 92%
“…Currently available anticoagulation methods for CRRT include the following categories: standard dose unfractionated heparin, regional citrate anticoagulation, low molecular weight heparin and heparinoid, regional heparinized anticoagulation, no anticoagulant, thrombin receptor antagonists, and platelet inhibitors, but no one anticoagulant regimen is suitable for all patients treated with CRRT, and the choice of anticoagulation regimen should be individualized. Among a variety of anticoagulants, heparin is easy to use, economical, easy to monitor, and can antagonize protamine when overdose, it is currently the most widely used anticoagulant for CRRT [ 2 ]. Heparin is an anionic sulfated mucopolysaccharide with a molecular weight of 5 kDa to 100 kDa, it forms complexes with antithrombin III in the blood, and the serine proteases of blood coagulation factors I, IX, XI, and XII lead to the rapid inactivation of these factors and plays an anticoagulant effect.…”
Section: Introductionmentioning
confidence: 99%
“…8 Therefore, it is of great significance to analyze the related factors affecting the quality of life of MHD patients. 9 In the MHD patients, serious degradation of bodily functions and self-care abilities, increase in complications, and the continuous development of corresponding symptoms, associated with the old age, seriously affect the quality of life. In a clinical study, Zhang L et al 10 showed that age is one of the main factors affecting quality of life of MHD patients.…”
Section: Discussionmentioning
confidence: 99%